Clinical Trial Update: Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of AndroGel in men with hypogonadism and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Type 2 Diabetes Mellitus

Drugs mentioned

• ANDROGEL (Testosterone)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Type 2 Diabetes, Hypogonadism | Phase 2 | Status: COMPLETED